摘要:
The present invention provides methods, pharmaceutical compositions, medicaments, and pharmaceutical kits that employ the use of boceprevir as a CYP3A4/5 inhibitor to improve the pharmacokinetics of therapeutic compounds metabolized by cytochrome P450 3A4/5 (CYP3A4/5) enzymes.
摘要:
Disclosed are medicaments, pharmaceutical compositions, pharmaceutical kits, and methods based on combinations comprising, separately or together: (a) a CYP3A4 inhibitor; and (b) a HCV protease inhibitor; for concurrent or consecutive administration in treating a human subject infected with HCV.
摘要:
A floor assembly (10) including a plurality of rectangular panels (12) disposed in end-to-end relationship in adjacent rows with the panels (12) of one row overlapping the panels (12) of the next adjacent row, the panels being in abutting edge to edge relationship. A groove (18) is disposed in each of the abutting edges and a dowel strip (20) is adhesively secured in one of the grooves (18) of the abutting edges of adjacent panels (12). A discrete and resilient block (22) extends downwardly from the bottom surface (16) of the corner of each panel (12) to engage a support surface. A plurality of hooks (26) engage the outer peripheral edges of the peripheral panels (12). Each of the hooks (26) includes a tubular element (36) secured to the bottom surface (16) and a cable (38) and a tensioning device (40) places the cable (38) in tension between the elements (36) of first and second hooks (26).